Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$17,221,451
+$543,311 QoQ
Shares Held
67,809
-0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
5.04%
of 13F equity value
Holder Rank
#809
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Bank holds $41,161,477 across 11 Drug Manufacturers - General names. JNJ ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
67,809 | $17,221,451 | |
| 2 | LLY |
ELI LILLY & Co
|
10,367 | $12,434,490 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,245 | $3,629,482 | |
| 4 | ABBV |
AbbVie Inc.
|
13,631 | $3,430,104 | |
| 5 | AMGN |
Amgen Inc
|
2,520 | $912,541 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,528 | $779,482 | |
| 7 | NVS |
Novartis AG
|
4,797 | $751,785 | |
| 8 | PFE |
Pfizer Inc
|
24,466 | $589,140 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,221,451 | 67,809 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $16,678,140 | 68,230 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $14,167,175 | 68,457 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $12,657,324 | 68,263 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $10,589,698 | 69,327 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $11,510,787 | 69,409 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $10,034,313 | 69,384 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $11,576,593 | 71,434 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $10,306,909 | 70,518 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $11,317,070 | 71,541 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $11,213,336 | 71,541 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $10,958,569 | 70,360 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $12,313,693 | 74,394 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $11,643,445 | 75,119 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $13,318,526 | 75,395 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $12,323,061 | 75,435 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $13,379,105 | 75,371 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $13,418,082 | 75,710 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $12,767,467 | 74,633 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $12,046,930 | 74,594 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $12,251,877 | 74,371 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $12,237,664 | 74,461 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $11,760,062 | 74,724 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $11,895,958 | 79,903 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $9,200,716 | 65,425 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $8,510,598 | 64,902 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||